Hemoglobinopathy Market, Global Outlook and Forecast 2023-2029

Report ID: MMG251328 | Category: Medical Care | Pages: 69 | Format: PDF | Published Date: October 26,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Hemoglobinopathies are a diverse set of congenital blood ailments that are a consequence of disparities in the structure and/or synthesis of hemoglobin. Hemoglobinopathies are genetic single-gene disorders that lead to an abnormal structure of one of the globin chains of the hemoglobin molecule, rendering it unable to carry oxygen through the body, which leads to anemia or other medical abnormalities. The most common hemoglobinopathies are sickle cell disease, alpha thalassemia, and beta thalassemia.
This report aims to provide a comprehensive presentation of the global market for Hemoglobinopathy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemoglobinopathy. This report contains market size and forecasts of Hemoglobinopathy in global, including the following market information:
Global Hemoglobinopathy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Hemoglobinopathy market was valued at US$ 277.8 million in 2022 and is projected to reach US$ 372.6 million by 2029, at a CAGR of 4.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Sickle Cell Disease Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hemoglobinopathy include Abbott Diagnostics, Bio-Rad Laboratories, Danaher Corporation, Mindray Medical International, Nexcelom Bioscience, Nihon Kohden, PerkinElmer, Siemens Healthineers and Sysmex Corporation, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hemoglobinopathy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hemoglobinopathy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Hemoglobinopathy Market Segment Percentages, by Type, 2022 (%)
    Sickle Cell Disease
    Alpha Thalassemia
    Beta Thalassemia
Global Hemoglobinopathy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Hemoglobinopathy Market Segment Percentages, by Application, 2022 (%)
    Hospitals
    Diagnostic Laboratories
    Clinics
Global Hemoglobinopathy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Hemoglobinopathy Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hemoglobinopathy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Hemoglobinopathy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Abbott Diagnostics
    Bio-Rad Laboratories
    Danaher Corporation
    Mindray Medical International
    Nexcelom Bioscience
    Nihon Kohden
    PerkinElmer
    Siemens Healthineers
    Sysmex Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hemoglobinopathy, market overview.
Chapter 2: Global Hemoglobinopathy market size in revenue.
Chapter 3: Detailed analysis of Hemoglobinopathy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hemoglobinopathy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Hemoglobinopathy Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Hemoglobinopathy Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Hemoglobinopathy Overall Market Size
    2.1 Global Hemoglobinopathy Market Size: 2022 VS 2029
    2.2 Global Hemoglobinopathy Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Hemoglobinopathy Players in Global Market
    3.2 Top Global Hemoglobinopathy Companies Ranked by Revenue
    3.3 Global Hemoglobinopathy Revenue by Companies
    3.4 Top 3 and Top 5 Hemoglobinopathy Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Hemoglobinopathy Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Hemoglobinopathy Players in Global Market
        3.6.1 List of Global Tier 1 Hemoglobinopathy Companies
        3.6.2 List of Global Tier 2 and Tier 3 Hemoglobinopathy Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Hemoglobinopathy Market Size Markets, 2022 & 2029
        4.1.2 Sickle Cell Disease
        4.1.3 Alpha Thalassemia
        4.1.4 Beta Thalassemia
    4.2 By Type - Global Hemoglobinopathy Revenue & Forecasts
        4.2.1 By Type - Global Hemoglobinopathy Revenue, 2018-2023
        4.2.2 By Type - Global Hemoglobinopathy Revenue, 2024-2029
        4.2.3 By Type - Global Hemoglobinopathy Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Hemoglobinopathy Market Size, 2022 & 2029
        5.1.2 Hospitals
        5.1.3 Diagnostic Laboratories
        5.1.4 Clinics
    5.2 By Application - Global Hemoglobinopathy Revenue & Forecasts
        5.2.1 By Application - Global Hemoglobinopathy Revenue, 2018-2023
        5.2.2 By Application - Global Hemoglobinopathy Revenue, 2024-2029
        5.2.3 By Application - Global Hemoglobinopathy Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Hemoglobinopathy Market Size, 2022 & 2029
    6.2 By Region - Global Hemoglobinopathy Revenue & Forecasts
        6.2.1 By Region - Global Hemoglobinopathy Revenue, 2018-2023
        6.2.2 By Region - Global Hemoglobinopathy Revenue, 2024-2029
        6.2.3 By Region - Global Hemoglobinopathy Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Hemoglobinopathy Revenue, 2018-2029
        6.3.2 US Hemoglobinopathy Market Size, 2018-2029
        6.3.3 Canada Hemoglobinopathy Market Size, 2018-2029
        6.3.4 Mexico Hemoglobinopathy Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Hemoglobinopathy Revenue, 2018-2029
        6.4.2 Germany Hemoglobinopathy Market Size, 2018-2029
        6.4.3 France Hemoglobinopathy Market Size, 2018-2029
        6.4.4 U.K. Hemoglobinopathy Market Size, 2018-2029
        6.4.5 Italy Hemoglobinopathy Market Size, 2018-2029
        6.4.6 Russia Hemoglobinopathy Market Size, 2018-2029
        6.4.7 Nordic Countries Hemoglobinopathy Market Size, 2018-2029
        6.4.8 Benelux Hemoglobinopathy Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Hemoglobinopathy Revenue, 2018-2029
        6.5.2 China Hemoglobinopathy Market Size, 2018-2029
        6.5.3 Japan Hemoglobinopathy Market Size, 2018-2029
        6.5.4 South Korea Hemoglobinopathy Market Size, 2018-2029
        6.5.5 Southeast Asia Hemoglobinopathy Market Size, 2018-2029
        6.5.6 India Hemoglobinopathy Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Hemoglobinopathy Revenue, 2018-2029
        6.6.2 Brazil Hemoglobinopathy Market Size, 2018-2029
        6.6.3 Argentina Hemoglobinopathy Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Hemoglobinopathy Revenue, 2018-2029
        6.7.2 Turkey Hemoglobinopathy Market Size, 2018-2029
        6.7.3 Israel Hemoglobinopathy Market Size, 2018-2029
        6.7.4 Saudi Arabia Hemoglobinopathy Market Size, 2018-2029
        6.7.5 UAE Hemoglobinopathy Market Size, 2018-2029
7 Hemoglobinopathy Companies Profiles
    7.1 Abbott Diagnostics
        7.1.1 Abbott Diagnostics Company Summary
        7.1.2 Abbott Diagnostics Business Overview
        7.1.3 Abbott Diagnostics Hemoglobinopathy Major Product Offerings
        7.1.4 Abbott Diagnostics Hemoglobinopathy Revenue in Global Market (2018-2023)
        7.1.5 Abbott Diagnostics Key News & Latest Developments
    7.2 Bio-Rad Laboratories
        7.2.1 Bio-Rad Laboratories Company Summary
        7.2.2 Bio-Rad Laboratories Business Overview
        7.2.3 Bio-Rad Laboratories Hemoglobinopathy Major Product Offerings
        7.2.4 Bio-Rad Laboratories Hemoglobinopathy Revenue in Global Market (2018-2023)
        7.2.5 Bio-Rad Laboratories Key News & Latest Developments
    7.3 Danaher Corporation
        7.3.1 Danaher Corporation Company Summary
        7.3.2 Danaher Corporation Business Overview
        7.3.3 Danaher Corporation Hemoglobinopathy Major Product Offerings
        7.3.4 Danaher Corporation Hemoglobinopathy Revenue in Global Market (2018-2023)
        7.3.5 Danaher Corporation Key News & Latest Developments
    7.4 Mindray Medical International
        7.4.1 Mindray Medical International Company Summary
        7.4.2 Mindray Medical International Business Overview
        7.4.3 Mindray Medical International Hemoglobinopathy Major Product Offerings
        7.4.4 Mindray Medical International Hemoglobinopathy Revenue in Global Market (2018-2023)
        7.4.5 Mindray Medical International Key News & Latest Developments
    7.5 Nexcelom Bioscience
        7.5.1 Nexcelom Bioscience Company Summary
        7.5.2 Nexcelom Bioscience Business Overview
        7.5.3 Nexcelom Bioscience Hemoglobinopathy Major Product Offerings
        7.5.4 Nexcelom Bioscience Hemoglobinopathy Revenue in Global Market (2018-2023)
        7.5.5 Nexcelom Bioscience Key News & Latest Developments
    7.6 Nihon Kohden
        7.6.1 Nihon Kohden Company Summary
        7.6.2 Nihon Kohden Business Overview
        7.6.3 Nihon Kohden Hemoglobinopathy Major Product Offerings
        7.6.4 Nihon Kohden Hemoglobinopathy Revenue in Global Market (2018-2023)
        7.6.5 Nihon Kohden Key News & Latest Developments
    7.7 PerkinElmer
        7.7.1 PerkinElmer Company Summary
        7.7.2 PerkinElmer Business Overview
        7.7.3 PerkinElmer Hemoglobinopathy Major Product Offerings
        7.7.4 PerkinElmer Hemoglobinopathy Revenue in Global Market (2018-2023)
        7.7.5 PerkinElmer Key News & Latest Developments
    7.8 Siemens Healthineers
        7.8.1 Siemens Healthineers Company Summary
        7.8.2 Siemens Healthineers Business Overview
        7.8.3 Siemens Healthineers Hemoglobinopathy Major Product Offerings
        7.8.4 Siemens Healthineers Hemoglobinopathy Revenue in Global Market (2018-2023)
        7.8.5 Siemens Healthineers Key News & Latest Developments
    7.9 Sysmex Corporation
        7.9.1 Sysmex Corporation Company Summary
        7.9.2 Sysmex Corporation Business Overview
        7.9.3 Sysmex Corporation Hemoglobinopathy Major Product Offerings
        7.9.4 Sysmex Corporation Hemoglobinopathy Revenue in Global Market (2018-2023)
        7.9.5 Sysmex Corporation Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Hemoglobinopathy Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?